31 5月 2019 by admin in UncategorizedComments Crescendo Biologics Announces Prestigious Academic Research Collaborations
28 5月 2019 by admin in UncategorizedComments Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
24 5月 2019 by admin in UncategorizedComments Crescendo Biologics Achieves Another Milestone in its Strategic Collaboration with Takeda
19 5月 2019 by admin in UncategorizedComments Crescendo awarded with EU patent on immunoglobulin libraries from transgenic animals
16 5月 2019 by admin in UncategorizedComments TEMPEST THERAPEUTICS STARTS PHASE I/IB CLINICAL TRIAL WITH FIRST-IN-CLASS PPAR ALPHA ANTAGONIST
15 5月 2019 by admin in UncategorizedComments resTORbio Reports First Quarter 2019 Financial Results and Corporate Update
